Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine - Gerotziafas, Grigoris T.; Catalano, Mariella; Colgan, Mary-Paula; Pecsvarady, Zsolt; Wautrecht, Jean Claude; Fazeli, Bahare; Olinic, Dan-Mircea; Farkas, Katalin; Elalamy, Ismail; Falanga, Anna; Fareed, Jawed; Papageorgiou, Chryssa; et al. (Thrombosis and haemostasis, 2020)
Keywords: Anticoagulants - therapeutic use; Cardiology; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - epidemiology; COVID-19 - diagnosis; COVID-19 - drug therapy; COVID-19 - epidemiology; Europe; Heparin, Low-Molecular-Weight - therapeutic use; Humans; Inflammation; Position Paper; Practice Guidelines as Topic; Risk Factors; Rivaroxaban - therapeutic use; SARS-CoV-2 - physiology; Societies, Medical; Thrombophilia; Thrombosis; Europe; COVID-19; cardiovascular disease; peripheral artery disease; deep vein thrombosis; antiplatelets; anticoagulants; low-molecular-weight heparin; DOAC; antithrombotic